×
About 37,845 results

ALLMedicine™ Liver Transplantation Center

Research & Reviews  13,204 results

Effect of Endoscopic Treatment in Patients with Secondary Sclerosing Cholangitis.
https://doi.org/10.1111/jgh.15977
Journal of Gastroenterology and Hepatology; Zhang CC, Sauer P et. al.

Aug 8th, 2022 - Secondary sclerosing cholangitis (SSC) is a progressive disease with high mortality and characterized by chronic inflammation and biliary obstruction. Therapeutic options are limited. The aim of this retrospective study was to evaluate the effects...

Liver Transplantation and the Use of Metamizole to Treat Drug-induced Liver Injury.
https://doi.org/10.1016/j.transproceed.2022.04.028
Transplantation Proceedings; Pohl J, Bischoff P et. al.

Aug 7th, 2022 - Metamizole, or dipyrone, is a frequently prescribed analgetic drug that can cause drug-induced liver injury (DILI). Still, there are only a few metamizole-associated DILI cases (n = 61, including our study) described in the literature. So far live...

Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay among Patients with He...
https://doi.org/10.1016/j.cgh.2022.07.031
Clinical Gastroenterology and Hepatology : the Official C... Wagle NS, Park S et. al.

Aug 7th, 2022 - Failures have been reported across the cancer care continuum in patients with hepatocellular carcinoma (HCC); however, the impact of treatment delays on outcomes has not been well characterized. We described the prevalence of treatment delays in a...

Acute Myeloid Leukaemia following Direct Acting Antiviral drugs in HCV-infected patient...
https://doi.org/10.1016/j.clinre.2022.102000
Clinics and Research in Hepatology and Gastroenterology; Carole S, Elena L et. al.

Aug 7th, 2022 - After several cases of peculiar hematological malignancies following introduction of new oral anti-hepatitis C virus (HCV) treatments in our recent practice, we aimed to systematically identify all cases of hematological malignancies (HM) in patie...

First report of auxiliary liver transplantation for severe cholangiopathy after SARS-Co...
https://doi.org/10.1111/ajt.17165
American Journal of Transplantation : Official Journal Of... Rela M, Rajakannu M et. al.

Aug 6th, 2022 - Post-coronavirus disease 2019 (COVID-19) cholangiopathy (PCC) is a new entity observed in patients recovering from severe COVID-19 pneumonia. Most patients recover with cholestasis improving over a period of time. In some patients cholestasis is s...

see more →

Guidelines  25 results

Non-invasive diagnosis and follow-up in liver transplantation.
https://doi.org/10.1016/j.clinre.2021.101774
Clinics and Research in Hepatology and Gastroenterology; Dumortier J, Besch C et. al.

Aug 1st, 2021 - The field of liver transplantation directly or indirectly embodies all liver diseases, in addition to specific ones related to organ rejection (cellular and humoral). The recommended non-invasive methods for determining the indication for liver tr...

Donor Warm Ischemia Time in DCD Liver Transplantation-Working Group Report From the ILT...
https://doi.org/10.1097/TP.0000000000003819
Transplantation Kalisvaart M, Croome KP et. al.

May 29th, 2021 - Donation after circulatory death (DCD) grafts are commonly used in liver transplantation. Attributable to the additional ischemic event during the donor warm ischemia time (DWIT), DCD grafts carry an increased risk for severe ischemia/reperfusion ...

Guidelines for Perioperative Care for Liver Transplantation: Enhanced Recovery After Su...
https://doi.org/10.1097/TP.0000000000003808
Transplantation Brustia R, Monsel A et. al.

May 10th, 2021 - Enhanced Recovery After Surgery (ERAS) is a multimodal, evidence-based, program of care developed to minimize the response to surgical stress, associated with reduced perioperative morbidity and hospital stay. This study presents the specific ERAS...

Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion...
https://doi.org/10.1097/TP.0000000000003573
Transplantation Martins PN, Rizzari MD et. al.

Mar 25th, 2021 - Recent trials in liver machine perfusion (MP) have revealed unique challenges beyond those seen in most clinical studies. Correct trial design and interpretation of data are essential to avoid drawing conclusions that may compromise patient safety...

Regulations and Procurement Surgery in DCD Liver Transplantation: Expert Consensus Guid...
https://doi.org/10.1097/TP.0000000000003729
Transplantation Hessheimer AJ, Polak W et. al.

Mar 7th, 2021 - Donation after circulatory death (DCD) donors are an increasingly more common source of livers for transplantation in many parts of the world. Events that occur during DCD liver recovery have a significant impact on the success of subsequent trans...

see more →

Drugs  18 results see all →

Clinicaltrials.gov  1,230 results

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
https://clinicaltrials.gov/ct2/show/NCT04086485

Aug 5th, 2022 - Background: Neuroendocrine tumors (NETs) of the gastrointestinal tract and pancreas are a rare and heterogeneous, but clinically important, group of neoplasms with unique tumor biology, natural history, and clinical management issues. While the tr...

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
https://clinicaltrials.gov/ct2/show/NCT05489523

Aug 5th, 2022 - A. Primary Aim To determine the safety and efficacy of tafamidis in patients who have undergone heart or combined heart/liver transplantation for ATTR (wild-type or variant) cardiac amyloidosis. Primary Hypothesis. Initiation of the TTR stabilizer...

Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers
https://clinicaltrials.gov/ct2/show/NCT00001204

Aug 4th, 2022 - Familial hypercholesterolemia is an autosomal co-dominant disorder resulting in abnormal LDL receptor function, profoundly elevated concentrations of low density lipoproteins, accelerated atherosclerosis and death by early adulthood. This disease ...

Atorvastatin Therapy on Xanthoma in Alagille Syndrome
https://clinicaltrials.gov/ct2/show/NCT05488067

Aug 4th, 2022 - Alagille syndrome (ALGS, OMIM 118450) is an important cause of chronic cholestasis in children, and the incidence rate is about 1:30000~1:50000. Most patients with ALGS have hypercholesterolemia. In severe cases, multiple xanthomas can be seen, an...

Study on the Quality of Life (QoL) After Liver Surgery
https://clinicaltrials.gov/ct2/show/NCT05464706

Aug 4th, 2022 - Liver cancer in adult men is the fifth most frequently diagnosed cancer worldwide, and is the second leading cause of cancer-related death in the world. In adult women, it is the seventh most commonly diagnosed cancer and the sixth leading cause o...

see more →

News  659 results

Past Decompensation in Alcoholic Hepatitis Not 'Absolute Contraindication' to Early Transplant
https://www.medscape.com/viewarticle/978309

Jul 29th, 2022 - Past decompensation in alcohol-associated hepatitis may be linked with worse survival following liver transplantation, but it's not all bad news, according to a retrospective study. Traditionally, patients with alcoholic liver disease were asked t...

Prior decompensation in alcohol-associated hepatitis not an ‘absolute contraindication’ for early liver transplant
https://www.mdedge.com/internalmedicine/article/256455/hepatology/prior-decompensation-alcohol-associated-hepatitis-not
Jim Kling

Jul 25th, 2022 - Past decompensation in alcohol-associated hepatitis may be linked with worse survival following liver transplantation, but it’s not all bad news, according to a retrospective study. Traditionally, patients with alcoholic liver disease were asked t.

Link Between Pediatric Hepatitis and Adenovirus 41 Still Unclear
https://www.medscape.com/viewarticle/977112

Jul 13th, 2022 - While two new studies reiterate a possible relationship between adenovirus 41 and acute hepatitis of unknown cause in children, whether these infections are significant or merely bystanders remains unclear. In both studies — one conducted in Alaba...

Statins in NAFLD: Taking a Closer Look at Benefits
https://www.medscape.com/viewarticle/976613

Jul 6th, 2022 - LONDON – Substantial reductions in liver fat and fibrosis can be achieved with statin therapy, according to research presented at the annual International Liver Congress sponsored by the European Association for the Study of the Liver. Statins are...

Statins in NAFLD: Taking a closer look at benefits
https://www.mdedge.com/internalmedicine/article/256014/gastroenterology/statins-nafld-taking-closer-look-benefits
Sara Freeman

Jul 5th, 2022 - LONDON – Substantial reductions in liver fat and fibrosis can be achieved with statin therapy, according to research presented at the annual International Liver Congress sponsored by the European Association for the Study of the Liver. Statins are.

see more →

Patient Education  2 results see all →